Chinese | English

Search in the results

HFCAS OpenIR

Browse/Search Results:  1-10 of 22 Help

Selected(0)Clear Items/Page:    Sort:
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文
THORACIC CANCER, 2022
Authors:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo;  Zhang, Yongchang;  Cai, Xiuyu;  Zhang, Shirong;  Lian, Bin;  Li, Wen;  Liu, Anwen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Xie, Congying;  Zhang, Junping;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Wang, Liping;  Zhu, Youcai;  Hu, Xiao;  Xie, Yanru;  Lin, Xinqing;  Cai, Jing;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Yao, Wang;  Shi, Xuefei;  Huang, Jianhui;  Chen, Huafei;  Zhang, Yinbin;  Sun, Pingli;  Wan, Bing;  Pang, Fei;  Xu, Zanmei;  Wang, Kai;  Xia, Yuanli;  Ye, Mingxiang;  Wang, Dong;  Wei, Qing;  Feng, Shuitu;  Zhou, Jianya;  Zhang, Jiexia;  Lv, Donglai;  Gao, Wenbin;  Kang, Jing;  Yu, Genhua;  Liang, Xianbin;  Yu, Chengtao;  Shi, Lin;  Yang, Nong;  Wu, Lin;  Hong, Zhuan;  Hong, Wei;  Fang, Meiyu;  Zhang, Yiping;  Lu, Yuanzhi;  Wang, Guansong;  Ma, Shenglin;  Si, Lu;  Fang, Wenfeng;  Song, Yong
Favorite  |  View/Download：9/0  |  Submit date：2022/12/23
checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects  
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文
THORACIC CANCER, 2022
Authors:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo;  Wang, Qian;  Liu, Aijun;  Yu, Jinpu;  Fang, Wenfeng;  Zhong, Wenzhao;  Wang, Zhijie;  Zhang, Yongchang;  Liu, Jingjing;  Zhang, Shirong;  Cai, Xiuyu;  Liu, Anwen;  Li, Wen;  Zhan, Ping;  Liu, Hongbing;  Lv, Tangfeng;  Miao, Liyun;  Min, Lingfeng;  Chen, Yu;  Yuan, Jingping;  Wang, Feng;  Jiang, Zhansheng;  Lin, Gen;  Pu, Xingxiang;  Lin, Rongbo;  Liu, Weifeng;  Rao, Chuangzhou;  Lv, Dongqing;  Yu, Zongyang;  Lei, Lei;  Li, Xiaoyan;  Tang, Chuanhao;  Zhou, Chengzhi;  Zhang, Junping;  Xue, Junli;  Guo, Hui;  Chu, Qian;  Meng, Rui;  Wu, Jingxun;  Zhang, Rui;  Hu, Xiao;  Zhou, Jin;  Zhu, Zhengfei;  Li, Yongheng;  Qiu, Hong;  Xia, Fan;  Lu, Yuanyuan;  Chen, Xiaofeng;  Ge, Rui;  Dai, Enyong;  Han, Yu;  Pan, Weiwei;  Luo, Jiancheng;  Jia, Hongtao;  Dong, Xiaowei;  Pang, Fei;  Wang, Kai;  Wang, Liping;  Zhu, Youcai;  Xie, Yanru;  Lin, Xinqin;  Cai, Jing;  Wei, Jia;  Lan, Fen;  Feng, Huijing;  Wang, Lin;  Du, Yingying;  Yao, Wang;  Shi, Xuefei;  Niu, Xiaomin;  Yuan, Dongmei;  Yao, Yanwen;  Huang, Jianhui;  Zhang, Yinbin;  Sun, Pingli;  Wang, Hong;  Ye, Mingxiang;  Wang, Dong;  Wang, Zhaofeng;  Wan, Bing;  Lv, Donglai;  Wei, Qing;  Kang, Jin;  Zhang, Jiatao;  Zhang, Chao;  Yu, Genhua;  Ou, Juanjuan;  Shi, Lin;  Li, Zhongwu;  Liu, Zhefeng;  Liu, Jing;  Yang, Nong;  Wu, Lin;  Wang, Huijuan;  Jin, Gu;  Yang, Liu;  Wang, Guansong;  Fang, Meiyu;  Fang, Yong;  Li, Yuan;  Wang, Xiaojia;  Zhang, Yiping;  Ma, Shenglin;  Wang, Biyun;  Zhang, Xiaotian;  Song, Yong;  Lu, Yuanzhi
Favorite  |  View/Download：11/0  |  Submit date：2022/12/22
fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase  
A randomized, controlled, multi-center, open-label study of adjuvant nab-paclitaxel plus S-1 (AS) versus capecitabine plus oxaliplatin (CapeOX) for stage III gastric cancer after D2 resection. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
Authors:  Yu, Pengfei;  Du, Yian;  Xu, Zhiyuan;  Yang, Litao;  Ying, Jieer;  Wang, Yongxiang;  Chen, Ping;  Wei, Yunhai;  Xu, Hongtao;  Xu, Nong;  Cheng, Xiangdong
Favorite  |  View/Download：8/0  |  Submit date：2022/12/23
Analytical study on magnetic component of geodesic acoustic mode 期刊论文
Physica Scripta, 2022, 卷号: 97
Authors:  Xie,Baoyi;  Ye,Lei;  Chen,Yang;  Zhao,Pengfei;  Guo,Wenfeng;  Xiang,Nong
Favorite  |  View/Download：7/0  |  Submit date：2022/12/22
geodesic acoustic mode  magnetic components  gyrokinetic equation  coupling of magnetic drift frequency  
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
Authors:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan;  Lizaso, Analyn;  Xu, Chunwei;  Liu, Jun;  Wang, Wenxian;  Song, Zhengbo;  Ou, Sai-Hong Ignatius;  Yang, Nong
Favorite  |  View/Download：30/0  |  Submit date：2022/05/05
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
Authors:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng;  Lin, Qin;  Wu, Gang;  Cui, Jiuwei;  Chang, Jianhua;  Cheng, Yufeng;  Huang, Cheng;  Liu, Anwen;  Yang, Nong;  Gong, Youling;  Zhu, Chuan;  Ma, Zhiyong;  Fang, Jian;  Chen, Gongyan;  Zhao, Jun;  Shi, Anhui;  Lin, Yingcheng;  Li, Guanghui;  Liu, Yunpeng;  Wang, Dong;  Wu, Rong;  Xu, Xinhua;  Shi, Jianhua;  Liu, Zhihua;  Cui, Na;  Wang, Jingru;  Wang, Qiang;  Zhang, Ran;  Yang, Jason;  Wu, Yi-Long
Favorite  |  View/Download：37/0  |  Submit date：2022/03/21
Numerical study on the loss of fast ions produced by minority ion cyclotron resonance heating in EAST 期刊论文
Plasma Science and Technology, 2021, 卷号: 23
Authors:  ZHANG,Dingzong;  HU,Youjun;  XIANG,Nong;  YANG,Cheng;  SHEN,Wei;  HUANG,Yanqing;  LIU,Hongbo
Favorite  |  View/Download：30/0  |  Submit date：2021/11/01
ion cyclotron resonance heating  the loss of fast ions  EAST  
Numerical and Experimental Evaluation of Shine-Through Loss and Beam Heating Due to Neutral Beam Injection on EAST 期刊论文
CHINESE PHYSICS LETTERS, 2021, 卷号: 38
Authors:  Wang, Jin-Fang;  Li, Ying-Ying;  Wu, Bin;  Chen, Yu-Qing;  Li, Jun;  Xu, Yong-Jian;  Chen, Long-Xi;  Hao, Bao-Long;  Zhou, Deng;  Huang, Juan;  Ding, Si-Ye;  Yang, Zhen;  Hou, Ya-Wei;  Liu, Xiao-Juan;  Xiang, Nong
Favorite  |  View/Download：17/0  |  Submit date：2021/08/31
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
Authors:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan;  Lizaso, Analyn;  Mao, Xinru;  Jin, Ren'an;  Zeng, Yu;  Li, Qinglin;  Wang, Jianbo;  Li, Yang;  Zhang, Yongchang;  Yang, Nong
Favorite  |  View/Download：24/0  |  Submit date：2021/03/15
Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer  
Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective 期刊论文
TUMORI JOURNAL, 2021
Authors:  Tong, Ying-hui;  Ding, Hai-ying;  Xin, Wen-xiu;  Zhong, Li-ke;  Xu, Gao-qi;  Zhang, Bo;  Yang, Guo-nong;  Fang, Luo
Favorite  |  View/Download：27/0  |  Submit date：2021/08/30
Cost-effectiveness  durvalumab  etoposide plus platinum chemotherapy  first-line treatment  SCLC